147 related articles for article (PubMed ID: 28528299)
1. Selective targeting and therapy of metastatic and multidrug resistant tumors using a long circulating podophyllotoxin nanoparticle.
Roy A; Zhao Y; Yang Y; Szeitz A; Klassen T; Li SD
Biomaterials; 2017 Aug; 137():11-22. PubMed ID: 28528299
[TBL] [Abstract][Full Text] [Related]
2. A highly tumor-targeted nanoparticle of podophyllotoxin penetrated tumor core and regressed multidrug resistant tumors.
Roy A; Ernsting MJ; Undzys E; Li SD
Biomaterials; 2015 Jun; 52():335-46. PubMed ID: 25818440
[TBL] [Abstract][Full Text] [Related]
3. A polypeptide based podophyllotoxin conjugate for the treatment of multi drug resistant breast cancer with enhanced efficiency and minimal toxicity.
Zhou H; Lv S; Zhang D; Deng M; Zhang X; Tang Z; Chen X
Acta Biomater; 2018 Jun; 73():388-399. PubMed ID: 29694920
[TBL] [Abstract][Full Text] [Related]
4. Transferrin receptor-targeted redox/pH-sensitive podophyllotoxin prodrug micelles for multidrug-resistant breast cancer therapy.
Li Y; Chen M; Yao B; Lu X; Zhang X; He P; Vasilatos SN; Ren X; Bian W; Yao C
J Mater Chem B; 2019 Oct; 7(38):5814-5824. PubMed ID: 31495855
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Tumor Penetration of Podophyllotoxin-Carboxymethylcellulose Conjugates with Various Chemical Compositions in Tumor Spheroid Culture and In Vivo Solid Tumor.
Yang Y; Roy A; Zhao Y; Undzys E; Li SD
Bioconjug Chem; 2017 May; 28(5):1505-1518. PubMed ID: 28437080
[TBL] [Abstract][Full Text] [Related]
6. The in vitro and in vivo anti-tumor effect of layered double hydroxides nanoparticles as delivery for podophyllotoxin.
Qin L; Xue M; Wang W; Zhu R; Wang S; Sun J; Zhang R; Sun X
Int J Pharm; 2010 Mar; 388(1-2):223-30. PubMed ID: 20045452
[TBL] [Abstract][Full Text] [Related]
7. Preclinical pharmacokinetic, biodistribution, and anti-cancer efficacy studies of a docetaxel-carboxymethylcellulose nanoparticle in mouse models.
Ernsting MJ; Tang WL; MacCallum NW; Li SD
Biomaterials; 2012 Feb; 33(5):1445-54. PubMed ID: 22079003
[TBL] [Abstract][Full Text] [Related]
8. Current Update of a Carboxymethylcellulose-PEG Conjugate Platform for Delivery of Insoluble Cytotoxic Agents to Tumors.
Yang Y; Bteich J; Li SD
AAPS J; 2017 Mar; 19(2):386-396. PubMed ID: 27873118
[TBL] [Abstract][Full Text] [Related]
9. Podophyllotoxin-polyacrylic acid conjugate micelles: improved anticancer efficacy against multidrug-resistant breast cancer.
Kumbhar PS; Sakate AM; Patil OB; Manjappa AS; Disouza JI
J Egypt Natl Canc Inst; 2020 Nov; 32(1):42. PubMed ID: 33191444
[TBL] [Abstract][Full Text] [Related]
10. Synergistic nanoparticulate drug combination overcomes multidrug resistance, increases efficacy, and reduces cardiotoxicity in a nonimmunocompromised breast tumor model.
Shuhendler AJ; Prasad P; Zhang RX; Amini MA; Sun M; Liu PP; Bristow RG; Rauth AM; Wu XY
Mol Pharm; 2014 Aug; 11(8):2659-74. PubMed ID: 24830351
[TBL] [Abstract][Full Text] [Related]
11. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD
Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307
[TBL] [Abstract][Full Text] [Related]
12. Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.
Yang X; Iyer AK; Singh A; Milane L; Choy E; Hornicek FJ; Amiji MM; Duan Z
Pharm Res; 2015 Jun; 32(6):2097-109. PubMed ID: 25515492
[TBL] [Abstract][Full Text] [Related]
13. Actively targeting D-α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer.
Jiang D; Gao X; Kang T; Feng X; Yao J; Yang M; Jing Y; Zhu Q; Feng J; Chen J
Nanoscale; 2016 Feb; 8(5):3100-18. PubMed ID: 26785758
[TBL] [Abstract][Full Text] [Related]
14. Nuclear-targeting TAT-PEG-Asp8-doxorubicin polymeric nanoassembly to overcome drug-resistant colon cancer.
Pan ZZ; Wang HY; Zhang M; Lin TT; Zhang WY; Zhao PF; Tang YS; Xiong Y; Zeng YE; Huang YZ
Acta Pharmacol Sin; 2016 Aug; 37(8):1110-20. PubMed ID: 27292613
[TBL] [Abstract][Full Text] [Related]
15. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticle Formulation Derived from Carboxymethyl Cellulose, Polyethylene Glycol, and Cabazitaxel for Chemotherapy Delivery to the Brain.
Bteich J; Ernsting MJ; Mohammed M; Kiyota T; McKee TD; Trikha M; Lowman HB; Sokoll KK
Bioconjug Chem; 2018 Jun; 29(6):2009-2020. PubMed ID: 29734804
[TBL] [Abstract][Full Text] [Related]
17. pH and ROS sequentially responsive podophyllotoxin prodrug micelles with surface charge-switchable and self-amplification drug release for combating multidrug resistance cancer.
Li C; Wang Y; Zhang S; Zhang J; Wang F; Sun Y; Huang L; Bian W
Drug Deliv; 2021 Dec; 28(1):680-691. PubMed ID: 33818237
[TBL] [Abstract][Full Text] [Related]
18. Targeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticle.
Ernsting MJ; Hoang B; Lohse I; Undzys E; Cao P; Do T; Gill B; Pintilie M; Hedley D; Li SD
J Control Release; 2015 May; 206():122-30. PubMed ID: 25804872
[TBL] [Abstract][Full Text] [Related]
19. Systemic delivery of nanoparticle formulation of novel tubulin inhibitor for treating metastatic melanoma.
Mundra V; Peng Y; Kumar V; Li W; Miller DD; Mahato RI
Drug Deliv Transl Res; 2015 Jun; 5(3):199-208. PubMed ID: 25924699
[TBL] [Abstract][Full Text] [Related]
20. Manipulation of pH-Sensitive interactions between podophyllotoxin-chitosan for enhanced controlled drug release.
Chen C; Yu Y; Wang X; Shi P; Wang Y; Wang P
Int J Biol Macromol; 2017 Feb; 95():451-461. PubMed ID: 27867056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
